Skip to main content
European Commission logo print header

Arrhythmogenic right ventricular cardiomyopathy / dysplasia: clinical registry and data base, evaluation of therapies, pathology registry, dna banking.

Cel

Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is a progressive, genetically determined cardiac disease that is a major cause of unexpected sudden death in the young and athlete in Europe. Because of its rarity, there is a need to collect data on a large scale, to set up a clinical and pathological registry to evaluate different treatments and to create a bank of DNA from affected families. The proposed research is a multidisciplinary multicenter collaborative study to investigate clinico-pathologic and genetic aspects of ARVC/D with these aims:
a) prospective longitudinal follow-up study to identify patients at risk of cardiac arrest;
b) evaluation of different therapies efficacy;
c) ultra structural and molecular pathology study to understand the etiopathogenesis;
d) genetic studies with the ultimate goal to identify the specific defective genes and the influence of the genotype on the clinical course.

Zaproszenie do składania wniosków

Data not available

System finansowania

CSC - Cost-sharing contracts

Koordynator

UNIVERSITA DEGLI STUDI DI PADOVA
Wkład UE
Brak danych
Adres
Via Gabelli 61
35121 Padova
Włochy

Zobacz na mapie

Koszt całkowity
Brak danych

Uczestnicy (8)